You are reading the article Attack Group “Orangeworm” Targets Healthcare Industry updated in February 2024 on the website Eastwest.edu.vn. We hope that the information we have shared is helpful to you. If you find the content interesting and meaningful, please share it with your friends and continue to follow and support us for the latest updates. Suggested March 2024 Attack Group “Orangeworm” Targets Healthcare Industry
Attack Group “Orangeworm” Targets Healthcare Industry
Name of the Malware?
Trojan.Kwampirs gives an ability to attackers with remote access to the compromised computer, which decrypts and excerpt a copy of DLL (Dynamic Link Library) which is a type of file that contains information that other programs can call upon to do certain things. Once infiltrated, the malware gathers all the data to send it back to a command-and-control server so, that the attackers can analyze which systems seem interested.
Orangeworm has been active since January 2024, and till date has infected a large number of organizations across the globe. They are planting “backdoor” remote-access software on medical computers which control MRI (Magnetic Resonance Machines) and X-ray Machines, in order to steal information from healthcare providers in the U.S., Europe and Asia.
According to security experts, this group of lone hackers looks for stealing patient information & sell it in black markets for amount ranging between US$25 and US$40 per record, while an email address sells for cents. Unlike ransomware, the attacks are highly targeted. It appears like the group chooses its targets very carefully and has conducted a good amount of planning before bombarding an attack.
The aggressors collect as much information as they can from back door system, and if the system seems interested and looks like not operated by security researchers, the malware- Trojan.Kwampirs will copy itself crosswise open network shares to infect other systems on the network.
As per reports, Orangeworm attackers were never afraid of being found, alongside they use movement methods which are quite noisy & obsolete. Despite of which, it took researchers 3 years to identify & discover the attack.
Who all are Targeted?
This malware attack has also affected related industries like pharmaceuticals, machinery manufacturers, healthcare providers and even IT solution providers which serve healthcare industry directly or indirectly.
According to reports, around 40% of the victims are companies activated in the healthcare industry, but attacks are floated towards other industries also that are somehow related to healthcare, including IT (15%), manufacturing (15%), logistics (8%), and agriculture (8%),
Orangeworm attempted a supply-chain attack by infecting a service provider to penetrate the networks of the desired healthcare organization.
Highlighting Trojan.Kwampirs spots all over the world. A huge number of victims are located in the U.S., accounting for 17% of the infection rate.
Motive Behind the Attack?
The reason behind choosing Healthcare Sector is the medical records which hospitals & institution store. These records are actual & have good authentic rate, which makes it very easy to identify the victim. The motives behind the attack are not much clear, but according to the statements of security experts, they actually target the medical records which are generally very rich in PII (Personal Identifiable Information) and have financial data associated with it.
Must Read: Warning! Your Six-digit iPhone Passcode is no longer Secure
According to reports by cybersecurity experts, the Orangeworm made no efforts to amend their malware after its first attacks, showing their extreme confidence that they would never get caught or high level of lunacy.Quick Reaction:
About the author
Tweak Library Team
You're reading Attack Group “Orangeworm” Targets Healthcare Industry
The applications of DL in healthcare is many, from improved diagnostics to enhance disease prediction
Deep learning, a subset of artificial intelligence (AI), has emerged as a revolutionary technology with profound applications in the healthcare industry. In healthcare, deep learning algorithms can be trained to analyze medical images, such as X-rays, MRIs, and CT scans, with remarkable accuracy, aiding in the early detection of diseases and improving diagnostic outcomes. These deep learning algorithms have also shown promise in drug discovery, genomics research, and clinical decision support systems. By harnessing the power of deep learning, healthcare providers can revolutionize patient care, improve efficiency, and ultimately save lives. This article will explore the diverse applications of deep learning in healthcare and their potential impact.
Deep learning, a subset of artificial intelligence (AI), has emerged as a powerful tool with transformative potential across various industries, including healthcare. With its ability to analyze vast amounts of complex data, deep learning holds promise for revolutionizing healthcare by improving diagnostics, personalized medicine, drug discovery, disease prediction, and more.1. Medical Imaging
Deep learning algorithms have demonstrated remarkable capabilities in interpreting medical images such as X-rays, CT scans, MRI scans, and mammograms. By training on large datasets, deep learning models can accurately identify patterns, anomalies, and early signs of diseases. This technology can assist radiologists in diagnosing conditions like cancer, cardiovascular diseases, and neurological disorders, leading to faster and more accurate diagnoses.2. Disease Diagnosis and Prediction
Deep learning models can aid in diagnosing diseases by analyzing patient data, including medical records, symptoms, genetic information, and laboratory results. By leveraging this information, deep learning algorithms can identify disease patterns and provide more accurate and timely diagnoses. Additionally, these models can predict the likelihood of developing certain diseases based on risk factors, allowing for early intervention and prevention.3. Drug Discovery and Development
The process of discovering and developing new drugs is time-consuming and costly. Deep learning can accelerate this process by analyzing vast amounts of biomedical data, including molecular structures, genomic data, and clinical trial results. By predicting the efficacy and safety of potential drug candidates, deep learning can help researchers identify promising molecules, optimize drug design, and reduce the time and cost associated with bringing new drugs to market.4. Personalized Medicine 5. Electronic Health Records (HER) Analysis
Deep learning can unlock valuable insights from electronic health records containing vast patient data. By analyzing this data, deep learning models can identify patterns, predict disease progression, and enable early intervention. Moreover, deep learning algorithms can improve HER accuracy by automatically extracting relevant information, reducing errors, and enhancing healthcare providers’ ability to make informed decisions.6. Clinical Decision Support Systems
Deep learning can be integrated into clinical decision support systems to aid healthcare professionals in making informed decisions. By analyzing patient data, medical literature, and treatment guidelines, deep learning models can provide recommendations on diagnosis, treatment plans, and medication options. These systems can enhance clinical decision-making, improve patient safety, and reduce medical errors.7. Disease Outbreak Prediction
Deep learning can analyze vast amounts of data, including social media feeds, news articles, and sensor data, to detect early signs of disease outbreaks. By identifying patterns and correlations, deep learning algorithms can predict disease spread, helping public health authorities allocate resources, implement preventive measures, and mitigate the impact of epidemics.
2024 promised to be one of the most challenging years the home healthcare industry had faced, even before it became one of the most challenging years the world had faced in a century. Home healthcare agencies were adjusting to the new Patient-Driven Groupings Model (PDGM) — the most significant change to their billing system in decades — and preparing to implement electronic visit verification (EVV) ahead of the 2023 federal deadline. Then COVID-19 came along and introduced new challenges.
But it also created new opportunities. When the pandemic began, Brandy Sparkman-Beierle was President of UH Home Care for University Hospitals, a home health, hospice, personal care and pharmacy network serving 4,000 patients in the Cleveland area. A registered nurse for 17 years with eight years’ experience in transitional care, Sparkman-Beierle was prepared to face admin challenges in 2023, and having used Homecare Homebase software since 2006, she knew her organization had the right tech partner to help. But like everyone else, she wasn’t prepared for the coronavirus.
“When COVID hit, elective surgeries were suddenly delayed or canceled,” says Sparkman-Beierle. “Patients were afraid to have clinicians in their homes, which resulted in increased LUPAs — low utilization rates that significantly lower reimbursement rates. PPE [personal protective equipment] was in short supply, so telehealth suddenly became a requirement, but it’s not a reimbursable service for home health, so we were seeing patients virtually but not getting paid — all while trying to keep patients and staff safe. The industry’s saving grace is that in home health, we know how to adapt quickly and overcome challenges.”
Home care agencies — especially those with forward-thinking leaders and innovative digital solutions like Homecare Homebase — have demonstrated their adaptability and resilience during the pandemic. They’ve also proven they can handle sicker, more complex patients than hospitals have usually entrusted to them, and they can do it more cost-effectively than inpatient facilities — while keeping everyone safer.Opportunities of healthcare’s new normal
After a sudden drop in patient census in the spring, many home care agencies have now rebounded to pre-COVID census levels or better. Most states have allowed hospitals to resume elective procedures, PPE is more widely available, and people are suddenly less confident in the safety of assisted-living facilities, skilled nursing homes and other communal senior care options. At the same time, hospitals have begun entrusting home care agencies with more complex cases — including COVID patients recovering at home and non-COVID patients who would usually spend a few more days in the hospital or spend some time in rehab before returning home.
Sparkman-Beierle, who joined Homecare Homebase in May as Senior Vice President of tech-enabled services, explains, “The pandemic allowed home health and hospice agencies to further demonstrate their value during this unprecedented time. Patients and families are really tapping into home-based care in lieu of outpatient visits, skilled nursing facilities and hospital admissions. The pandemic demonstrated the vast capabilities and the complex care we can actually provide in the home — a patient’s most sacred place and where most people would prefer to recover.”
The federal government agrees. In September, Centers for Medicare & Medicaid Services (CMS) administrator Seema Verma announced, “The tragic devastation wrought by the coronavirus on nursing home residents exposes America’s over-reliance on institutional long-term care facilities. Residential care will always be an essential part of the care continuum, but our goal must always be to give residents options that help keep our loved ones in their own homes and communities for as long as possible.”
Verma also pointed out that home healthcare is “not only frequently more cost effective, but is preferred by seniors and adults with disabilities seeking to maintain the dignity of independent living.”Homecare Homebase ushers agencies through digital transformation
Increased demand is good news for home care agencies, but they’re still facing the same challenges as before — adapting to PGDM, preparing for EVV and meeting the needs of a growing and aging population despite a healthcare talent shortage and a pandemic that often forces workers to quarantine for seven to 14 days.
As the leading electronic health record (EHR) software for home-based care, Homecare Homebase addresses all these challenges and more, helping home health and hospice agencies achieve an average 3.8 star rating (versus the national average of 3.3 stars).Your definitive guide to EVV compliance
Discover how mobile solutions can can help your agency satisfy your state’s EVV requirements. Download Now
“Homecare Homebase isn’t just a software product; it’s also a tried-and-true operating model,” says Neal Reizer, Senior Vice President of product management. “The software focuses on the compliance and utilization management aspects of running a business at scale — allowing you to grow your business without necessarily adding staff — and it provides a rich set of analytics that give you visibility into clinical and financial operations across your organization. But we also work with the top 10 agencies in the country, and we listen to those customers and seek out their feedback about workflows and best practices. And we connect our customers with each other, so when you bring on Homecare Homebase, you’re joining the top operators in the country and have access to them as peers.”
From a clinician perspective, Homecare Homebase’s mobile EHR solution, which comes preloaded on Samsung Galaxy tablets, keeps care providers connected to the people and data they need to do their jobs, without impeding their connection to patients.
“When we were using laptops and paperwork, the laptop always seemed like a barrier between the clinician and the patient,” says Sparkman-Beierle. “The Samsung tablet creates that connection with the patient where they don’t feel like there’s a barrier between them and their caregiver. I can put the tablet in my coat pocket if I’m doing a physical exam, and the touchscreen is very helpful as well.”Coping with COVID
During the height of the pandemic, clinicians were also using their Samsung tablets to conduct virtual visits, often while sitting outside their patients’ homes, venturing inside only long enough to complete hands-on tasks. These new ways of working required new integrations, and Homecare Homebase made that a top priority.
“Our customers were rapidly acquiring telemedicine and remote monitoring technology, so we shifted our interoperability team to focus on new integrations,” says Reizer. “But we didn’t really have to make any material application changes to our software in support of COVID-19, because there are so many out-of-the-box capabilities in the platform that we were able to leverage very quickly. Within four weeks, we released dashboards that allow agencies to identify and locate COVID patients, along with CDC [Centers for Disease Control and Prevention] screening guidelines.”
Reizer says agencies that have not only survived, but actually thrived, during the pandemic are the ones that have forward-thinking leaders and innovative technology. “If you’re a good operator, if you’ve got good relationships with your referral sources and good operational standards and guidelines, if you’ve got good management oversight, if you’re using data to drive your decisions about branch effectiveness and your overall financial health and clinical outcomes — I think you absorbed COVID better than your peers. COVID was a pressure test for leadership. Because most of our customers were led very well, and their teams had the technology they needed to work effectively and efficiently, I think that’s why they were able to weather this, and some have even come out stronger.”
Discover new ways that healthcare professionals are delivering value-based care in the COVID era. Then learn how to establish a successful remote patient monitoring program in this free guide.
Why Is There A Compelling Need for BI in Manufacturing?
Manufacturing costs are increasing rapidly coupled with declining profit margins. Increased regulations from governments are also making the path harder to traverse. In this backdrop, the demand for simple, data-driven insights is greater than ever. Moreover, manufacturing is one of the most data-intensive industries. From reaching out to customers to delivering products, by nature, manufacturing is an extensively data-intensive industry. However, most of these data often lie idle with the companies. So,Informed Decision-Making
With the huge influx of data from multiple sources, there arises a need for proper management, storage, and utilization of all these data. BI can help in management and utilization of data from multiple sources. BI tools can access large, cumbersome database and transform it into an easily comprehensible structure. With the help of visualization tools, the analysis can be presented in a simplified manner along with key business matrices and KPIs to business executives. This helps the decision-makers to take a more informed and concise decision. Information from all sources can be sophistically incorporated in the decision making. It can also test ‘what if’ scenarios to project and analyze alternate strategies. This, in turn, increases the risk-taking capability of a business.Increases Operational Efficiency
BI accelerates the pace of operational efficiency by making huge volumes of data readily accessible and understandable. It can help in analyzing team performances and suggesting remedial measures for proper allocation of scarce resources. Product modeling through analytics helps to reduce and correct errors during product development. By incorporating viable financial models, BI can evaluate capacity and material requirement periodically. Almost every complex process from production to shipping can be simplified by using BI. From constantly changing market demands to sales strategy, forecasting and supply chain management, BI can take care of all. It also helps to bring more transparency to the network.Financial Management
BI tools can be used for profit and loss analysis, sales analysis, raw material analysis, and thus help in optimizing resources and increase ROI. Both external profit building and internal cost reductions are necessary to improve the profit margin. BI can help in this case by identifying new unexplored channels of revenue and minimizing internal costs. It allows to do an in-depth cost-benefit analysis that helps companies to manage production costs through multiple information layers. It also helps to streamline operational procedures by managing and monitoring processes. With demand-supply analysis, BI can control value chain more efficiently.Supply Chain and Logistics Management
BI can help in managing the supply chain logistics by evaluating its performance on a daily basis and analyzing data to ensure timely deliveries and quality service. It can monitor freight costs by identifying changes in supply and demand. It can also help to optimize the value of suppliers by giving feedback on their services. Thus, BI can help to evaluate shipment performances and accordingly negotiate contracts.Inventory Control
Inventory control and management is one of the most crucial operations of a manufacturing firm. It is one of the biggest assets of any firm and can regulate the performance of the firms accordingly. It can also help in tracking and reducing inventory costs across location and time. Testing and simulating new manufacturing products also becomes easier. This helps in reduced process flaws by pin-pointing defects. It can also analyze turnover rates and margins based on products, departments and sellers.Conclusion
Pattern of Life: Lives Linked by Drone Attack New Rep, BCAP stage BU alum’s new play
Nael Nacer (left) and Lewis D. Wheeler portray men from two different worlds in Pattern of Life, Walt McGough’s new play about the human toll of a drone attack. The play runs through June 29 at the BU Theatre. Photo courtesy of New Repertory Theatre
Walt McGough, a playwright with a boundless imagination, has conjured compelling drama from space alien houseguests and deranged spies. In his new play, Pattern of Life, McGough (GRS’12), links the lives of a drone pilot responsible for the death of a young boy and a Pakistani in the village where the innocent victim lived. Directed by Bridget Kathleen O’Leary (CFA’07), the play is presented by New Repertory Theatre, as part of its Next Voices Playwriting Fellowship, and the College of Fine Arts Boston Center for American Performance (BCAP).
In the world premiere, which runs through June 29 at the Boston University Theatre, the pilot is consumed by guilt over the boy’s mistaken death thousands of miles away. Through dreams, he connects with a Pakistani villager, struggling to comprehend the tragedy and put a face on a faceless enemy. Through their shared dreams, they become human to each other as they explore questions of revenge, justice, and connection in a time of endless warfare.
New Rep’s joining with BCAP, the professional arm of the CFA School of Theatre, is a reflection of the sowing of theater partnerships and opportunities for young actors and designers envisioned by Jim Petosa, a CFA professor and director of the School of Theatre, who took over New Rep’s artistic directorship in 2012. Next Voices “has allowed New Rep to tap into the energy of emerging playwrights and their work,” says New Rep managing director Harriet Sheets. “As one of New Rep’s playwriting fellows, Walt has been able to develop Pattern of Life over the past year through workshops and readings, allowing him to finely tune this amazing new play.”
“Walt has the incredible ability to create challenging, beautiful, and complex plays that provide audiences with almost endless variety,“ says O’Leary, New Rep associate artistic director. “Pattern of Life benefits from Walt’s thoughtfulness as a playwright, and it has been a pleasure to work with him throughout the year to bring this play to life.”
A Huntington Theatre Company playwriting fellow, McGough has earned three Independent Reviewers of New England (IRNE) Award nominations for Best New Play. His works include The Farm, Priscilla Dreams the Answer, Chalk, and The Haberdasher! He won the 2011 Best Comedy Award from the Capital Fringe Festival in Washington, D.C., and was named one of the Boston Globe’s 2012 Artists on the Rise. He received the Kennedy Center’s Ken Ludwig Playwriting Scholarship in 2010 and is a founding ensemble member of Sideshow Theatre Company in Chicago.
O’Leary has directed numerous New Rep productions, including Lungs, Fully Committed, Collected Stories, Dollhouse, Charles Dickens’ A Christmas Carol, and Fool for Love. She joined New Rep in 2008.
Pattern of Life runs from June 14 to 29, 2014, at the Boston University Theatre Lane-Comley Studio 210, 264 Huntington Ave., Boston. Tickets are $30 general admission, $15 for students with a valid college ID, and may be purchased online or by calling the New Rep box office at 617-923-8487; group discounts are available. By public transportation, take an MBTA Green Line E trolley to Symphony or the Orange Line to Massachusetts Avenue; by bus, take the number 11 Harvard-Dudley bus via Massachusetts Avenue to Huntington Avenue or the number 39 Arborway-Copley bus to Gainsborough Street.
Explore Related Topics:
The intersection of artificial intelligence (AI) and cryptocurrency has given birth to a new wave of innovation in the financial world. As blockchain technology continues to reshape traditional industries, integrating AI algorithms and crypto assets has opened up new possibilities for investors seeking substantial growth opportunities.
In this exciting landscape, a promising newcomer has emerged, capturing the attention of crypto enthusiasts and forward-thinking investors’ attention. InQubeta (QUBE), the groundbreaking crypto gem to bridge the gap between AI startups and investors, has disrupted the crypto space with its seamless, innovative technology, aiming to achieve an unprecedented 100x growth.
Let’s explore the features that make QUBE a compelling investment opportunity with a target of 100x growth and how AI technology has been integrated into the crypto ecosystem.InQubeta (QUBE) allows Investors To Embrace the Dynamic World of AI Technology.
InQubeta is the world’s first crypto crowdfunding platform that unlocks the potential for fractional investment in AI startups using QUBE tokens. This deflationary ERC20 token is on track with a remarkable goal of achieving 100x growth that will leave a lasting mark, thanks to its streamlined technology causing a lot of buzz within the crypto market.
However, investing in AI technology beckons with excitement because its dynamic nature holds an infinite capacity for innovation and growth in machine learning, robotics, and beyond. This provides a strong prospect of profit for investors looking for the best AI crypto to buy, and venturing into these promising startups can be challenging and risky.
But Inqubeta makes it easier for investors by being a guiding light that addresses the challenges head-on. With a visionary approach, the project has crafted a platform that bridges the divide between investors and AI startups, fostering a more accessible and democratic investment ecosystem for all. This feature has propelled the QUBE DeFi token to the forefront within the crypto world, causing many crypto whales to onboard the platform.
In addition, the platform leverages the inherent power of blockchain and smart contracts to create a transparent and secure investment process. As the best AI crypto to buy, its groundbreaking approach instills confidence in investors and enthusiasts, propelling it toward achieving 100x growth. This unique combination of factors sets InQubeta apart from other crypto platforms, positioning it as the best crypto choice for investments and portfolio diversification.
Visit InQubeta PresaleExperience the Power of InQubeta’s (QUBE) Trending NFT Marketplace
InQubeta introduces one of the best NFT marketplaces that open new avenues for startups to raise funds while offering an enticing reward and equity-based NFTs. Investors can immerse themselves in this platform, where investment opportunities are transformed into one-of-a-kind NFTs, meticulously minted and fractionalized.
Also, QUBE DeFi token holders can effortlessly invest in projects they believe in, forming a symbiotic ecosystem of mutual benefits. A 2% tax on transactions fuels the token’s deflationary nature, boosting its value over time. A 5% sell tax also contributes to a dedicated reward pool, unlocking captivating rewards for staked tokens and fostering financial gratification and emotional connection. With this strategic approach, QUBE ignites a flame of 100x potential growth, propelling the journey forward.Final Thoughts
As the possibilities of AI and crypto collide, the world holds its breath in anticipation. QUBE, the new crypto gem, beckons investors to participate in this transformative journey. InQubeta distinguishes itself with its trending NFT platform and unique features. Seizing the chance to be part of cutting-edge technology where extraordinary opportunities await gives investors access to invest in any AI startup they prefer. Don’t hesitate to unlock the infinite possibilities by joining the InQubeta project today. Purchase your QUBE ERC20 tokens and pave your way to a future filled with success and prosperity.
Update the detailed information about Attack Group “Orangeworm” Targets Healthcare Industry on the Eastwest.edu.vn website. We hope the article's content will meet your needs, and we will regularly update the information to provide you with the fastest and most accurate information. Have a great day!